ATC kodları
- L01EL Bruton'un tirozin kinaz (BTK) inhibitörleri
- L01EL01 ibrutinib
- L01EL02 acalabrutinib
- L01EL03 zanubrutinib
- L01EM Fosfatidilinositol-3-kinaz (Pi3K) inhibitörleri
- L01EM01 idealalisib
- L01EM02 kopanlisib
- L01EM03 alpelisib
- L01EM04 duvelisib
- L01EX ATC'deki diğer protein kinaz inhibitörleri
- L01EX01 sunitinib
- L01EX02 sorafenib
- L01EX03 pazopanib
- L01EX04 vandetanib
- L01EX05 regorafenib
- L01EX06 masitinib
- L01EX07 cabozantinib
- L01EX08 lenvatinib
- L01EX09 nintedanib
- L01EX10 midostaurin
- L01EX11 kizartinib
- L01EX12 larotrektinib
- L01EX13 gilteritinib
- L01EX14 entrectinib
- L01EX15 pexidartinib
- L01EX16 erdafitinib
- L01EX17 kapmatinib
- L01EX18 avapritinib
- L01EX19 ripretinib
- L01EX20 pemigatinib
- L01EX21 tepotinib
- L01X ATC'DEKİ DİĞER ANTİNEOPLASTİK AJANLAR
- L01XA Platin bileşikleri, antineoplastik ilaçlar
- L01XA01 sisplatin
- L01XA02 karboplatin
- L01XA03 okzaliplatin
- L01XA04 satraplatin
- L01XA05 poliplatillen
- L01XB Metilhidrazinler, antineoplastikler
- L01XB01 prokarbazin
- L01XC Monoklonal antikorlar, antineoplastik
- L01XC01 edrekolomab
- L01XC02 rituksimab
- L01XC03 trastuzumab
- L01XC05 gemtuzumab ozogamisin
- L01XC06 setuksimab
- L01XC07 bevacizumab
- L01XC08 panitumumab
- L01XC09 katumaksomab
- L01XC10 ofatumumab
- L01XC11 ipilimumab
- L01XC12 brentuksimab vedotin
- L01XC13 boğmaca
- L01XC14 trastuzumab emtansin
- L01XC15 obinutuzumab
- L01XC16 dinutuksimab beta
- L01XC17 nivolumab
- L01XC18 pembrolizumab
- L01XC19 blinatumomab
- L01XC21 ramucirumab
- L01XC22 necitumumab
- L01XC23 elotuzumab
- L01XC24 daratumumab
- L01XC25 mogamulizumab
- L01XC26 inotuzumab ozogamisin
- L01XC27 olaratumab
- L01XC28 durvalumab
- L01XC29 bermekimab
- L01XC31 avelumab
- L01XC32 atezolizumab
- L01XC33 cemiplimab
- L01XC34 moksetumomab pasudotoksu
- L01XC35 tafasitamab
- L01XC36 enfortumab vedotin
- L01XC37 polatuzumab vedotin
- L01XC38 isatuximab
- L01XC39 belantamab mafodotin
- L01XC40 dostarlimab
- L01XC41 trastuzumab deruxtecan
- L01XD Fotodinamik/radyasyon tedavisinde kullanılan hassaslaştırıcılar
- L01XD01 porfimer sodyum
- L01XD03 metil aminolevulinat
- L01XD04 aminolevulinik asit
- L01XD05 temoporfin
- L01XD06 efaproksiral
- L01XD07 padeliporfin
- L01XF Kanser tedavisi için retinoidler
- L01XF01 tretinoin
- L01XF02 alitretinoin
- L01XF03 beksaroten
- L01XG Proteazom inhibitörleri, antineoplastik ajan
- L01XG01 bortezomib
- L01XG02 carfilzomib
- L01XG03 iksazomib
- L01XH Histon deasetilaz (HDAC) inhibitörleri
- L01XH01 vorinostat
- L01XH02 romidepsin
- L01XH03 panobinostat
- L01XH04 belinostat
- L01XH05 entinostat